The Problem
Identifying the right discovery or contract research partner is often slow and inefficient.
Outsourcers consistently struggle to compare CROs with differing scientific capabilities, disease focus, technologies, and capacity. RFIs can often be too broad, leading to irrelevant responses and time-consuming follow-ups.
The result?
Delays selecting CRO partners
High internal effort managing enquiries
Slower progression of discovery and development programs